121 related articles for article (PubMed ID: 9079790)
1. Ethological and 6-[18F]fluoro-L-DOPA-PET profiles of long-term vulnerability to chronic amphetamine.
Melega WP; Raleigh MJ; Stout DB; Huang SC; Phelps ME
Behav Brain Res; 1997 Mar; 84(1-2):259-68. PubMed ID: 9079790
[TBL] [Abstract][Full Text] [Related]
2. Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey.
Melega WP; Raleigh MJ; Stout DB; Lacan G; Huang SC; Phelps ME
Brain Res; 1997 Aug; 766(1-2):113-20. PubMed ID: 9359594
[TBL] [Abstract][Full Text] [Related]
3. 6-[18F]fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys.
Melega WP; Quintana J; Raleigh MJ; Stout DB; Yu DC; Lin KP; Huang SC; Phelps ME
Synapse; 1996 Jan; 22(1):63-9. PubMed ID: 8822479
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal behavioral and 6-[18F]fluoro-L-DOPA-PET assessment in MPTP-hemiparkinsonian monkeys.
Melega WP; Raleigh MJ; Stout DB; DeSalles AA; Cherry SR; Blurton-Jones M; Morton GG; Huang SC; Phelps ME
Exp Neurol; 1996 Oct; 141(2):318-29. PubMed ID: 8812167
[TBL] [Abstract][Full Text] [Related]
5. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
6. Striatal 18F-dopa uptake: absence of an aging effect.
Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
[TBL] [Abstract][Full Text] [Related]
7. Comparative assessment of 6-[
Becker G; Bahri MA; Michel A; Hustadt F; Garraux G; Luxen A; Lemaire C; Plenevaux A
J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of an 18F-labeled dopa prodrug as a PET tracer for studying brain dopamine metabolism.
Ishiwata K; Shinoda M; Ishii S; Nozaki T; Senda M
Nucl Med Biol; 1996 Apr; 23(3):295-301. PubMed ID: 8782240
[TBL] [Abstract][Full Text] [Related]
9. Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles.
Melega WP; Jorgensen MJ; Laćan G; Way BM; Pham J; Morton G; Cho AK; Fairbanks LA
Neuropsychopharmacology; 2008 May; 33(6):1441-52. PubMed ID: 17625500
[TBL] [Abstract][Full Text] [Related]
10. Naloxone does not alter amphetamine-induced rotational behavior or striatal dopamine levels of nigrally-lesioned rats.
Kimmel HL; Schad CA; Justice JB; Holtzman SG
Brain Res; 1998 Apr; 789(1):171-4. PubMed ID: 9602114
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate.
Kuczenski R; Segal DS
Psychopharmacology (Berl); 1999 Nov; 147(1):96-103. PubMed ID: 10591874
[TBL] [Abstract][Full Text] [Related]
12. The neurochemical basis for the behavioral effects of triadimefon.
Hill D; Ikaiddi M; Mazzio E; Soliman KF
Ann N Y Acad Sci; 2000 Sep; 914():336-53. PubMed ID: 11085334
[TBL] [Abstract][Full Text] [Related]
13. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
[TBL] [Abstract][Full Text] [Related]
14. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
Von Voigtlander PF; Moore KE
Neuropharmacology; 1973 May; 12(5):451-62. PubMed ID: 4145343
[No Abstract] [Full Text] [Related]
15. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
[TBL] [Abstract][Full Text] [Related]
16. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
[TBL] [Abstract][Full Text] [Related]
17. 6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
Barrio JR; Huang SC; Melega WP; Yu DC; Hoffman JM; Schneider JS; Satyamurthy N; Mazziotta JC; Phelps ME
J Neurosci Res; 1990 Dec; 27(4):487-93. PubMed ID: 2127807
[TBL] [Abstract][Full Text] [Related]
18. Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
Forsback S; Niemi R; Marjamäki P; Eskola O; Bergman J; Grönroos T; Haaparanta M; Haapalinna A; Rinne J; Solin O
Synapse; 2004 Feb; 51(2):119-27. PubMed ID: 14618679
[TBL] [Abstract][Full Text] [Related]
19. Maternal immune activation in late gestation enhances locomotor response to acute but not chronic amphetamine treatment in male mice offspring: role of the D1 receptor.
Zager A; Mennecier G; Palermo-Neto J
Behav Brain Res; 2012 Jun; 232(1):30-6. PubMed ID: 22487249
[TBL] [Abstract][Full Text] [Related]
20. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
Psylla M; Günther I; Antonini A; Vontobel P; Reist HW; Zollinger A; Leenders KL
Brain Res; 1997 Aug; 767(1):45-54. PubMed ID: 9365014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
